The ischemic preconditioning effect of adenosine in patients with ischemic heart disease
Open Access
- 5 November 2009
- journal article
- research article
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 7 (1) , 52
Abstract
In vivo and in vitro evidence suggests that adenosine and its agonists play key roles in the process of ischemic preconditioning. The effects of low-dose adenosine infusion on ischemic preconditioning have not been thoroughly studied in humans.Keywords
This publication has 22 references indexed in Scilit:
- Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trialEuropean Heart Journal, 2006
- Electrocardiographic infarct size assessment after thrombolysis: Insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAmerican Heart Journal, 2005
- Ischemic preconditioning decreases the reperfusion-related formation of hydroxyl radicals in a rabbit model of regional myocardial ischemia and reperfusion: The role of KATPchannelsFree Radical Research, 2005
- Ischemic preconditioning and preinfarction angina in the clinical arenaNature Clinical Practice Cardiovascular Medicine, 2004
- Cardiac protection during acute myocardial infarction: Where do we stand in 2004?JACC, 2004
- Analgesic effects of adenosine during exercise-provoked myocardial ischaemiaNeuroReport, 1996
- Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.Circulation, 1994
- Preconditioning the human myocardiumThe Lancet, 1993
- Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.Circulation Research, 1992
- Different degrees of ischemic threshold stratified by the dipyridamole-echocardiography testThe American Journal of Cardiology, 1987